Jump to navigation
The Drug Utilization Review (DUR) Board serves in an advisory capacity to the Department of Health Care Policy and Financing and makes recommendations regarding issues of drug utilization, provider education interventions, and application of standards. The DUR Board also determines the prior authorization criteria for drugs with special prescribing guidelines and the prior authorization criteria for non-preferred drugs, those that don't make the Preferred Drug List (PDL).
Our meeting has a standing location:
Skaggs School of Pharmacy and Pharmaceutical Sciences
Seminar Room - Room 1000; First Floor12850 E. Montview Blvd., Aurora, CO 80045* Parking Available in the Henderson/Visitor Parking Garage
DUR Open Session: 6:00 p.m. - 9:00 p.m.
The Board meets quarterly.
Closed Session: 6:00 p.m. - 7:00 p.m.
Open Session: 7:00 p.m. - 9:00 p.m.
The Board consists of nine members appointed by the Executive Director; four physicians, four pharmacists licensed and actively practicing in Colorado, and one non-voting pharmaceutical industry representative.
Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.